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Abstract
Purpose The aim of this study is to investigate the relation-
ships among reactive oxygen species (ROS) elevation, histone
transition, and seminal cytokine concentrations.
Methods Total levels of ROS in semen samples from 6560
men were measured. From this sample, 118 cases with high
ROS and 106 controls were recruited. Basic semen parameters
and histone-to-protamine ratios were analyzed, 400 semen
cytokine and receptor alterations were assayed by protein
chip, and finally 18 cytokines were validated in each sample
using a Bio-Plex Cytokine assay.
Results The results showed that the seminal ROS concentra-
tion was associated with abnormalities in the sperm histone
transition. Compared with controls, 93 cytokines had signifi-
cant alterations in the high ROS cases, with 14 of them further
verified in individual samples. The concentrations of CXCL5,
CXCL16, CXCL8, IL-1b, IL-10, CSF3, CCL3, and TNF-α
were significantly correlated with the histone transition ratio.
In addition, IL-16 showed significantly different concentra-
tions in controls, normal semen with high ROS levels, and
abnormal semen with high ROS levels.
Conclusions Semen ROS are associated with abnormalities in
sperm histone transition. CXCL5, CXCL8, IL-16, CCL8,
CCL22, CCL20, CXCL16, IL-1B, IL-6, IL-7, IL-10, CSF3,
CCL3, CCL4, and TNF-α all have elevated concentrations in
semen with high ROS levels. These data might help to explain
the mechanisms behind the increase in the levels of ROS and
seminal cytokines and their relationship with defective
spermatogenesis.
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Introduction
Male infertility has become a prevalent worldwide problem in
recent decades. The incidence of infertility is approximately
15 %, with about 50 % due to male infertility [1]. Reactive
oxygen species (ROS) constitute a potentially considerable
environmental risk factor for infertility. Smoking, drinking,
radiation, toxins, infection, and inflammation have all been
correlated with elevated ROS in humans [2]. ROS play a
potentially impactful role in male reproductive biology [3]:
High levels of ROS in semen might damage cellular mem-
branes and oxidize protective lipids and are therefore nega-
tively correlated with many sperm function parameters [3–5].
In the clinic, elevated ROS levels are observed in patients with
abnormal sperm motility and morphology, and oxidative
stress plays a critical role in male factor infertility in those
with high levels of ROS [6].
Cytokines are polypeptide regulatory factors that are in-
volved in the immune response, cellular growth and differen-
tiation, inflammation, and repair. In the male genital tract,
cytokines are produced by the testes and regulate the prolifer-
ation of germ cells and differentiation of mesenchymal cells
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Association of semen cytokines with reactive oxygen species
and histone transition abnormalities
and play a part in steroid anabolism [7, 8]. Several cytokines
in seminal plasma have been correlated with semen quality
parameters such as sperm concentration, motility, viability,
and morphology [9, 10]. For example, Naz et al. proposed
that the concentration of interleukin (IL)-12 was positively
correlated with the number and normal morphology of sperm
[11], while Fraczek et al. determined that under in vitro con-
ditions, IL-12 could bind to IL-18 and destroy the sperm plas-
ma membrane and DNA integrity [12]. In addition, the levels
of several cytokines (IL-6, IL-8, TNF-α, IL-10) are elevated
in men with genital infections and could play roles in the
immune defense of the male genital tract [13].
An increasing number of studies have reported in recent
years that ROS and cytokines possess a complex and exquisite
interplay. Although ROS can promote the expression and pro-
duction of cytokines, some cytokines can modulate pro-
oxidant and antioxidant systems and the generation of ROS
[14–16]. Several studies have documented the association be-
tween cytokines and ROS. For instance, high levels of IL-6
and IL-8 promote the peroxidation process, affecting the func-
tion of sperm and causing infertility during inflammation of
the male genital tract [14]. In infertile patients with varico-
celes, increased levels of IL-6 and ROS might reduce the total
antioxidant capacity [15]. In addition, men with chronic pros-
tatitis and elevated levels of TNF-α in semen had increased
physiologic concentrations of MDA (an oxidative stress prod-
uct) in seminal plasma and damaged sperm function [16].
Therefore, seminal cytokines could be involved in various
pathologic conditions connected to male infertility and inter-
act with oxidative stress and cellular ROS, which might then
lead to defective sperm function.
Histone-to-protamine transition is a key step in the estab-
lishment of epigenetic stability in spermatozoa, and the
histone-to-protamine exchange rate in humans is around
85 % [17]. Abnormalities in histone-to-protamine transition
in humans are associated with defective spermatogenesis and
male infertility, and this process might be affected by oxida-
tive stress in the testis [18]. Because it is not possible to di-
rectly measure the ROS levels in the human testis, an assay of
seminal ROS could serve as an alternative. Several experi-
ments have suggested a link between testicular oxidative
stress and semen ROS levels. For instance, vitamin C has a
protective effect in the testes of adult male rats, and seminal
plasma ascorbic acid is negatively correlated with semen ROS
signals [19, 20]. In the clinic, seminal ROS levels are signif-
icantly correlated with varicoceles, which can cause oxidative
stress in the testis [21]. Therefore, the ROS detected in semen
might reflect an imbalance between ROS generation and deg-
radation in the male reproductive system, including the testis.
The aim of our present study was to investigate the rela-
tionships among high semen ROS, poor sperm quality, and
seminal cytokine concentrations in infertile men. We screened
the ROS concentrations of 6560 men and recruited 118
infertile males with high ROS as case samples and 106 nor-
mozoospermicmales with lowROS as controls.We compared
sperm function parameters, analyzed 400 semen cytokine al-
terations by protein chip technology, and further verified 18
cytokines in the two groups using Luminex xMAP technology
with the Bio-Plex System.
Materials and methods
Subjects
This study was approved by the institutional review board of
Guangzhou Medical University. All studies involving human
subjects were conducted in accordance with Declaration of
Helsinki guidelines. We obtained written informed consent
from all participants and collected data regarding medical his-
tory and smoking status via a structured questionnaire. Study
subjects were ethnic Han Chinese in southern China who had
a semen examination in the Third Affiliated Hospital of
Guangzhou Medical University from March 2014 to
June 2015 for fertility assessment. Their smoking status was
obtained by the survey and included the frequency of smoking
(cigarettes/day) and years of smoking (years). After the clini-
cal examination, the left part of the semen was used for ROS
level analysis. In total, 14,278 semen samples were subjected
to the initial ROS screening. Because most patients underwent
at least two semen analyses in the clinic, 6560 men underwent
a ROS measurement, with the initial results showing that 458
subjects had elevated ROS levels (ROS levels >40 relative
light units [RLU]/s). We used 40 RLU/s as the critical value
because it is the 95th percentile value for ROS levels among
normal males [6].
Our study cases were then recruited from the 458 subjects
based on the following inclusion criteria: (1) 20–40 years old,
(2) consistent results from two or more semen tests, (3) semen
samples collected by masturbation, and (4) no known diseases
related to ROS elevation or no other conditions that might be
related to ROS. Exclusion indications were (1) azoospermia,
(2) hematospermia, (3) necrozoospermia (survival rate
<58 %), (4) chromosomal or hormonal abnormalities, AZF
deletions, or other known genetic diseases, (5) white cell con-
tamination or polymorphonuclear granulocytes (PMNs)
>1 × 106/ml semen, and (6) diabetes, infections, or other dis-
eases. Age- and smoking status-matched, normozoospermic
controls were randomly picked. They were men with low
ROS levels (ROS levels <40 RLU/s) who met all inclusion
criteria and exclusion indications.
Finally, 118 cases and 106 controls were enrolled in this
study, classified into the cases group and control group. Based
on their sperm parameters, cases were further stratified into
two subgroups: Case 1 (n = 81) included men with normal
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semen parameters and high ROS, and case 2 (n = 37) included
men with abnormal semen parameters and high ROS.
Semen collection and analysis
The semen samples were collected using the standard method
according to the World Health Organization [22]. All semen
specimens from patients and controls were collected by mas-
turbation into sterile containers. Immediately after liquefac-
tion, fresh sperm concentration and percent motility were
assessed using a computer-assisted sperm analysis system
(Hamilton Thorne, Beverly, MA). PMNs were enumerated
by peroxidase staining under microscopy. For spermmorphol-
ogy and vitality evaluations, seminal smears were stained and
assessed under microscopy according to World Health
Organization guidelines.
Determination of ROS levels
The ROS levels in fresh semen were determined within 2 h of
sample collection using 5-amino-2,3-dihydro-1,4-
phthalazinedione (Luminol, Sigma) as the probe according
to the literature [6]. First, 2 μl of 25 mM luminol (dissolved
in dimethyl sulfoxide, Sigma) and 8 μl of 755 IU/ml HRP
(260 IU/mg) were added to 200 μl of neat semen. ROS levels
were determined by measuring chemiluminescence (BioTek
Synergy H1, USA). The results are expressed as relative light
units per second (RLU/s). After the parameters were mea-
sured, the sperm and seminal plasma were separated by cen-
trifugation at 500×g and stored at −80 °C for further cytokine
analysis.
Aniline blue staining
The ratio of histone-to-protamine in sperm nuclei was mea-
sured using a Nucleoprotein Transition Test Kit (Huakang
Company, Shenzhen, China). Briefly, 5 μl of prepared sper-
matozoa were spread onto a glass slide and allowed to dry.
The smears were fixed in 3 % buffered glutaraldehyde in 0.2-
M phosphate buffer (pH 7.2) for 30 min. The slides were then
stained with 5 % aqueous aniline blue mixed with 4 % acetic
acid (pH 3.5) for 5 min. Positive staining indicates abnormal
histone-to-protamine transition. A total of 400 sperm cells
were evaluated under microscopy, and the percentage of
stained sperm heads was calculated.
Protein chip analysis
Due to the large number of cases and controls, a mixture of
samples was analyzed using a protein chip and differently
expressed cytokines were validated in each sample using a
Bio-Plex Cytokine assay (Bio-Rad). The seminal cytokines
were initially analyzed by Quantibody Human Cytokine
Antibody Array 9000 (RayBiotech, GA, US). All samples
from controls and all samples from cases were mixed by equal
volume to create a case mixture and control mixture. In total,
400 cytokines and receptors were analyzed in both control and
case mixtures according to the manufacturer’s protocol.
Briefly, slide chips with control and case mixtures were
completely dried for 1–2 h and then closed and incubated
overnight. After the overnight incubation, the spots were
washed twice. After incubation with biotin-labeled antibody
for 2 h at room temperature, each spot was washed with wash-
ing buffer and 70 μl of diluted fluorescent agent (streptavidin-
biotin [Cy3 equivalent]) was added to each well. The device
was then covered with aluminum foil to avoid exposure to
light and incubated for 1 h at room temperature. Water drop-
lets were completely removed by applying gentle suction.
Fluorescence detection was analyzed using laser scanners
(Axon GenePix, USA) using Cy3 or the green channel (at
an excitation frequency of 532 nm). Experiments were con-
ducted in triplicates for the final analysis.
Assay of cytokine concentrations using the Bio-Plex
System
Detection and quantification of cytokines in frozen thawed
seminal plasma were performed using the Bio-Plex Cytokine
assay (Bio-Rad). Prior to the experiment, we prepared solu-
tions of standards, antibody dilutions, and streptavidin-PE.
Experiments were conducted in accordance with the manufac-
turer’s instructions. First, 50-μl beads were added to pre-wet
wells (for the filter plate only). After two washes, 50 μl of
standards, blank, or samples were added to each well and
incubated at room temperature with shaking at 850 rpm.
After three washes with wash buffer, 25 μl of detection anti-
body was added and the wells were incubated for 30 min at
room temperature with shaking at 850 rpm. After three
washes, 50-μl streptavidin-PE was added and the wells were
incubated for 10 min. Finally, the beads in each well were
resuspended in 125 μl of assay buffer and shaken at
850 rpm for 30 s, and the entire plate was read on the Bio-
Plex system.
Statistical analyses
The independent sample t test was used to analyze numerical
data in two groups. The Mann-Whitney test was used to ana-
lyze nonhomogenous variables. The Spearman correlation co-
efficient was used to examine the associations between ROS
levels and semen parameters as well as ROS levels and cyto-
kines. P values of <0.05 (two-sided probability) were
interpreted as statistically significant. Statistical analyses were
conducted using SPSS statistical software (version 13.0)
(SPSS Inc., Chicago, IL).
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Results
Age, smoking status, semen parameters, and ROS levels
of study subjects
The summary statistics of the semen parameters analyzed
in the different populations are presented in Table 1.
There were 106 controls with low ROS levels and 118
cases with high ROS levels. The two groups had a similar
average age, years of smoking, and smoking frequency,
but the level of histone transition abnormalities was sig-
nificantly different. Sperm parameters, including concen-
tration, motility, vitality, and malformation rate, were sig-
nificantly different between cases and controls because
the cases group contained patients with both high ROS
and abnormal semen parameters.
Correlations between ROS and sperm quality
ROS levels were correlated with most sperm quality parame-
ters in the case subjects (Table 2), including sperm concentra-
tion, sperm vitality, sperm progressive motility, sperm
immotility, and malformation rate. In addition, ROS levels
were positively correlated with histone transition
abnormalities.
Protein chip analysis of cytokines and receptors
in the study groups
Four hundred cytokines and receptors were analyzed in
the case subjects and controls using protein chip analysis.
Significantly differentially expressed cytokines were se-
lected, as defined by a signal value greater than 200 and
fold change (expression level in case subjects/expression
level in controls) greater than 2 or less than 0.5 (Table 3).
The final results revealed that 93 cytokines were differen-
tially expressed between the case subjects and controls.
Of these, the CXCL5, CCL22, CCL8, and TGFB1 levels
were significantly higher in the cases, with fold changes
greater than 10, and IL-5Ra and TACSTD1 were signifi-
cantly lower in the case subjects, with fold changes less
than 0.2.
Bio-Plex analysis of cytokines in study groups
To further confirm the protein chip assay data, cytokine con-
centrations were assayed in all 224 subjects using the Bio-Plex
system (Table 4). The following 18 cytokines and chemokines
were detected in this assay: CXCL5, CXCL6, CXCL8, IL-16,
CCL8, CCL7, CCL22, CCL20, CCL19, CXCL16, IL-1B, IL-
6, IL-7, IL-10, CSF3, CCL3, CCL4, and TNF-α. To distin-
guish between different subgroups in the case subjects, these
samples were further stratified into two groups: Case group 1
comprised patients with normal semen parameters but high
ROS, and the case group 2 comprised patients with abnormal
semen parameters with high ROS. Most of the cytokines test-
ed had significantly higher concentrations in the case groups
than in the control subjects, including CXCL5, CXCL8, IL-
16, CCL8, CCL20, IL-1B, IL-6, IL-7, IL-10, CSF3, CCL3,
CCL4, and TNF-α. However, the differences in CXCL6,
CCL7, CCL22, and CCL19 expression did not reach statisti-
cal significance. In addition, IL-16 showed significantly dif-
ferent concentrations between the control, case 1, and case 2
groups, respectively.
Table 1 Age, smoking status, semen parameters, and ROS levels of
study subjects
Parameters Controls Cases
Subject number 106 118
Age (years) 32.42 ± 3.71 32.62 ± 4.04
Smoking yearsa 1.06 ± 1.37 1.32 ± 1.19
Smoking frequency 0.92 ± 1.18 1.09 ± 0.95
Sperm concentration (×106 cells/ml) 76.27 ± 45.78 70.09 ± 56.69*
Semen volume (ml) 3.50 ± 1.39 3.00 ± 1.19**
Sperm progressive motility (%) 63.59 ± 9.65 47.75 ± 18.81**
Sperm immotility (%) 29.37 ± 10.68 46.66 ± 20.57**
Sperm vitality (%) 88.54 ± 3.54 81.36 ± 10.46**
Malformation rate (%) 95.11 ± 4.19 96.80 ± 3.04**
Histone transition abnormalityb 9.79 ± 4.76 14.32 ± 8.65**
ROS range (RUL/s) 0–40 41–5627
Semen ROS (RUL/s/106 sperm) 1.14 ± 2.12 260.87 ± 405.07
Controls: semen samples with low ROS; cases: semen samples with high
ROS. Data are presented as mean ± SD unless otherwise noted
*P < .05 and **P < .01 compared with controls
a Information of smoking dose (packs per day) and years smoked was
acquired from subjects
b The abnormality in histone transition was the percentage of sperm cells
that had elevated histone-to-protamine ratios
Table 2 Correlations between ROS and sperm quality parameters
Parameters r p
Smoking frequency 0.113 0.091
Smoking duration 0.114 0.094
Age −0.014 0.83
Sperm concentration −0.429** <0.01**
Semen volume −0.147* 0.029
Sperm vitality −0.412** <0.01**
Sperm progressive motility −0.558** <0.01**
Sperm immotility 0.573** <0.01**
Malformation rate 0.383 <0.01**
Histone transition abnormality 0.306** <0.01**
**Correlation was significant at the 0.01 level (two-tailed)
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Correlations among cytokines, ROS, and sperm quality
Table 5 lists the correlations among cytokines, ROS, and
sperm quality in all of our study subjects (cases plus controls).
CCL3, CXCL5, CXCL8, CSF3, IL-10, IL-1B, TNF-α, and
IL-6 were found to be significantly correlated with the histone
transition ratio in seminal plasma. Sperm concentration was
negatively correlated with IL-6, sperm vitality was negatively
correlated with CXCL5, CXCL8, IL-1b, IL-6, IL-10, TNF-α,
CSF3, CCL3, IL-16, CCL20, and CCL8, and sperm progres-
sive motility was also negatively correlated with CXCL5,
CXCL8, IL-1b, IL-6, IL-10, TNF-α, CSF3, CCL3, IL-16,
CCL20, and CCL8. Moreover, ROS concentrations were pos-
itively correlated with the concentrations of CXCL5, CXCL8,
IL-1b, IL-6, IL-10, TNF-α, CSF3, CCL3, IL-7, IL-16,
CCL20, and CCL8.
Discussion
The present study is the first to report that semen ROS is
associated with abnormalities in sperm histone transition
(Table 2). Because protamines in mature sperm can change
DNA neutrality, inhibit RNA synthesis, and prevent sperm
gene expression in seminal plasma [18, 23, 24], an abnormal
histone-to-protamine transition may interfere with the stability
of sperm DNA, disrupt normal depolymerization in sperm
nuclei, and eventually lead to decreased sperm fertilizing po-
tential and embryonic development [25, 26]. In this way, high
ROS levels may, by interfering with sperm epigenetic stabil-
ity, be one of the risk factors for unexplained miscarriages and
embryo development failure.
The detailed mechanisms involved in ROS induction of
histone transition abnormalities have not yet been reported,
Table 3 Protein-chip analysis of
cytokines and receptors in cases
and controls
Official symbol Fold changea Official symbol Fold changea Official symbol Fold changea
CXCL5 15.3 LIF 3.4 SDC3 2.3
CCL22 14.8 FTL 3.3 GNLY 2.3
CCL8 11.5 EDA2R 3.3 GDF15 2.3
TGFBI 11.1 CXCL1 3.3 MCF R 2.3
CXCL6 9.4 NOTCH1 3.1 FRZB 2.3
CSF3 9.0 IL3 3.1 TNFRSF1B 2.2
IL1B 7.9 IL33 3.1 GDNF 2.2
S100A8 7.4 GAS1 3.1 IL16 2.2
IL7 6.5 F3 3.1 CD274 2.2
MICA 6.4 CCL20 3.0 RARRES2 2.2
MET 6.3 IL32 3.0 MUC16 2.2
IL6 6.2 C5a 3.0 IGFBP6 2.2
MMP9 6.1 PDCD1 2.9 CD80 2.2
CCL4 5.9 CCL7 2.9 LGALS1 2.2
C16orf77 5.7 CSF1 2.8 CRP 2.2
CCL3 5.7 FURIN 2.8 ADAM17 2.2
IL-18 4.9 CD97 2.7 BMP2 2.2
IL10 4.6 FGF19 2.6 HGF 2.2
MMP13 4.6 TNFRSF13B 2.6 PRSS8 2.1
IL8 4.4 PECAM1 2.5 CHL1 2.1
IL20 4.2 ROBO3 2.5 MME 2.1
ICAM1 4.2 CCL17 2.5 IL5 2.1
MMP10 4.0 IL17RA 2.5 CXCL9 2.0
CCL24 4.0 THBD 2.5 MMP8 2.0
RETN 3.9 CXCL16 2.4 TLR2 2.0
ADIPOQ 3.8 MMP1 2.4 PGLYRP1 2.0
CCL19 3.8 SIGLEC7 2.4 KIT 2.0
RGMB 3.7 CD200 2.3 LYVE1 0.3
SIGLEC5 3.6 CDH3 2.3 IL1F9 0.3
FAP 3.6 TNFRSF10D 2.3 IL5RA 0.2
WIF1 3.5 OLR1 2.3 TACSTD1 0.2
a Fold change = expression level in cases/expression level in controls
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but recent studies have found that ROS could lead to alter-
ations in sperm DNA methylation [27]. A molecular study
suggested that oxidative stress and ROS can impair the pro-
cess of DNA methylation by inhibiting substrate synthesis or
decreasing the activity of epigenetic enzymes such as DNMT
and HDAC [28–31]. It is unclear if ROS can impair the
histone-to-protamine transition in a similar manner and further
investigation is thus warranted.
The literature shows that cytokines related to male genital
tract infections may promote the generation of ROS [32, 33].
Several previous studies also showed that interleukins such as
IL-6 and IL-8 and the cytokine TNF-α play an important role
in the inflammatory process [15, 34]. In our study, the con-
centrations of many immune cytokines were elevated in the
case groups with high levels of ROS but without infections or
other diseases (Tables 3 and 4). For instance, IL-16 is a CD4
chemoattractant, CXCL8 (IL-8) is a PMN chemoattractant,
IL-1B is a leukocyte activator that increases endothelium ad-
hesion, IL-6 is a hematopoiesis factor related to the differen-
tiation and inflammation of T and B cells, IL-7 is a pre-/pro-b
cell proliferation and pro-inflammatory cytokine, IL-10 is a T
and B cell activator that inhibits IFN-r, TNF-b, and IL-2,
CSF3 (G-CSF) stimulates the growth and differentiation of
granulocytes, TNF-α is a mediator of inflammatory reactions,
and CXCL5 (ENA-78), CCL8 (MCP-2), CCL2 (MIP-3a),
CCL (MIP-1a), and CCL4 (MIP-1b) are all chemokines that
stimulate leukocyte movement. Therefore, elevated levels of
these cytokines in patients with high ROS levels suggest that
excessive ROS might be associated with the immune re-
sponse, even though no immune diseases were detected.
Validation of some cytokine alterations in each subject
showed that certain cytokines found to be altered in the protein
chip assay were also changed at the individual level.
Cytokines such as CXCL5 (ENA-78), CXCL8 (IL-8), IL-16,
IL-1b, IL-6, IL-10, CCL3 (MIP-1a), and CCL4 (MIP-1b) ex-
hibited increased levels in semen with high ROS compared
with controls, suggesting that their concentrations are tightly
linked to seminal ROS levels (Table 4). One cytokine, IL-16,
showed significantly different concentrations among controls,
normal semen with high ROS, and abnormal semen with high
ROS (Table 4).
Further analysis revealed that although the aforemen-
tioned cytokines all appeared to be associated with semen
ROS and sperm quality, they could potentially be classi-
fied into three types of cytokines (Table 5). The first of
these types, which included CXCL5 (ENA-78), CXCL8
(IL-8), IL-1b, IL-6, IL-10, TNF-α, CSF3 (G-CSF), and
CCL3 (MIP-1a), was associated with all semen quality
parameters including concentration, vitality, motility, his-
tone transition abnormalities, and semen ROS levels. The
second type, including IL-7, IL-16, and CCL20 (MIP-3a),
was associated with common semen parameters and
Table 4 Concentrations of










P1 P2 P3 P4
CXCL5 605.17 6107.71 4392.90 9870.78 <0.01** <0.01** <0.01** 0.20
CXCL6 8205.34 9026.83 9021.59 9038.19 0.855 0.951 0.759 0.855
CXCL8 505.63 2419.65 1919.96 3486.57 <0.01** <0.01** <0.01** 0.501
IL16 54.33 345.66 186.09 686.37 <0.01** <0.01** <0.01** <0.05*
CCL8 65.06 255.24 319.75 113.68 <0.05* <0.05* <0.05* 0.546
CCL7 77.79 100.54 88.14 127.03 0.914 0.932 0.921 0.955
CCL22 669.89 1161.39 985.81 1536.28 0.088 0.128 0.206 0.815
CCL20 723.49 2605.39 2358.24 3133.09 <0.01** <0.01** <0.01** 0.600
CCL19 40.51 42.20 40.39 46.05 0.996 0.986 0.984 0.993
CXCL16 765.74 721.01 708.89 746.89 0.063 <0.05* 0.589 0.293
IL1B 1.63 30.88 25.15 44.03 <0.01** <0.01** <0.01** 0.256
IL6 16.90 103.44 66.22 188.82 <0.01** <0.01** <0.01** 0.062
IL7 863.28 690.68 728.74 603.38 <0.01** <0.05* <0.01** 0.082
IL10 2.81 14.52 11.42 21.65 <0.01** <0.01** <0.01** 0.580
CSF3 30.75 198.98 202.77 190.27 <0.01** <0.01** <0.01** 0.957
CCL3 2.06 36.02 21.93 68.35 <0.01** <0.01** <0.01** 0.339
CCL4 95.79 525.47 393.96 827.17 <0.01** <0.01** <0.01** 0.425
TNF-α 5.41 24.57 20.59 33.72 <0.01** <0.01** <0.01** 0.882
Controls, semen samples with low ROS. Case 1, normal semen parameters with high ROS. Case 2, abnormal
semen parameters with high ROS. Cases: Case 1 + Case 2
P1 control vs. cases, P2 control vs. cases1, P3 control vs. case 2, P4 case 1 vs. case 2
*P < 0.05; **P < 0.01
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semen ROS, but not histone transition abnormalities. The
third type of cytokine, including CCL8 (MCP-2), was
associated with only semen vitality and ROS. We specu-
lated that this classification reflects the degree of associ-
ation of cytokines with spermatogenesis. If the cytokines
are associated with several pathways in spermatogenesis,
we concluded that ROS may be linked with additional
semen parameters. Based upon this possibility, cytokines
such as TNF-α, CSF3 (G-CSF), and CCL3 (MIP-1a) are
thus more likely to be closely associated with defective
spermatogenesis.
Our current data also revealed that certain cytokines were
significantly correlated with the histone-to-protamine ratio
(Table 5). The concentrations of CXCL5, CXCL16, and
TNF-α were found to be significantly correlated with the his-
tone transition ratio, suggesting that cytokines are involved in
mechanisms of altered protamine expression and excessive
ROS and that they exist in a complex regulatory interplay
during histone transition. This linkage might exist because
cytokines are directly involved in the histone transition pro-
cess or because histone transition is highly associated with
sperm quality. However, we do not yet have enough details
on this linkage.
In conclusion, we have found in our present study that
the semen ROS levels are associated with abnormalities in
the sperm histone transition pathway. CXCL5, CXCL8,
IL-16, CCL8, CCL22, CCL20, CXCL16, IL-1B, IL-6,
IL-7, IL-10, CSF3, CCL3, CCL4, and TNF-α all have
elevated concentrations in semen with high ROS levels.
In addition, IL-16 shows significantly different concentra-
tions among normal semen with low ROS levels, normal
semen with high ROS levels, and abnormal semen with
high ROS levels. Therefore, our current findings provide
further insights into the causes of high ROS and the un-
derlying mechanisms.
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Table 5 Correlations among cytokines, ROS, and sperm quality in all subjects
Cytokines CXCL5/ENA-78 CXCL8/IL-8 IL1b IL6
r p r p r p r p
Sperm concentration −0.045 0.519 −0.020 0.768 −0.126 0.070 −0.174 <0.05*
Sperm vitality −0.294 <0.01** −0.323 <0.01** −0.319 <0.01** −0.334 <0.01**
Sperm progressive motility −0.226 <0.01** −0.360 <0.01** −0.384 <0.01** −0.403 <0.01**
Malformation rate 0.070 0.317 0.134 0.052 0.145 <0.05* 0.269 <0.01**
Histone transition abnormality 0.319 <0.01** 0.230 <0.01** 0.204 <0.05* 0.194 <0.05*
ROS 0.541 <0.01** 0.680 <0.01** 0.716 <0.01** 0.659 <0.01**
Cytokines IL10 TNF-α CSF3/G-CSF CCL3/MIP-1a
r p r p r p r p
Sperm concentration −0.108 0.120 −0.081 0.247 −0.122 0.080 −0.129 0.063
Sperm vitality −0.303 <0.01** −0.239 <0.01** −0.299 <0.01** −0.319 <0.01**
Sperm progressive motility −0.338 <0.01** −0.378 <0.01** −0.371 <0.01** −0.397 <0.01**
Malformation rate 0.210 <0.01** 0.208 <0.01** 0.201 <0.01** 0.208 <0.01**
Histone transition abnormality 0.207 <0.05* 0.277 <0.01** 0.214 <0.05* 0.224 <0.05*
ROS 0.676 <0.01** 0.667 <0.01** 0.704 <0.01** 0.752 <0.01**
Cytokines IL7 IL16 CCL20/MIP-3a CCL8/MCP-2
r p r p r p r p
Sperm concentration 0.100 0.149 −0.107 0.122 −0.032 0.639 −0.011 0.873
Sperm vitality 0.071 0.309 −0.320 <0.01** −0.215 <0.01** −0.153 <0.05*
Sperm progressive motility 0.153 <0.05* −0.315 <0.01** −0.178 <0.01** −0.111 0.108
Malformation rate 0.006 0.935 0.185 <0.01** 0.059 0.393 0.088 0.207
Histone transition abnormality −0.051 0.564 0.141 0.110 0.058 0.511 −0.101 0.257
ROS −0.233 <0.01** 0.647 <0.01** 0.473 <0.01** 0.155 <0.05*
Analyzed by Spearman’s correlation analysis, *P< 0.05, **P< 0.01
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